Thomas C. Heineman
Affiliations: | Saint Louis University, St. Louis, MO, United States |
Area:
Molecular Biology, Microbiology Biology, Virology BiologyGoogle:
"Thomas Heineman"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bernstein DI, Flechtner JB, McNeil LK, et al. (2019) Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease. Vaccine |
| McNeil LK, Baccari A, Clemens V, et al. (2017) Significant Neutralizing Antibody and Cytolytic T Cell Responses to GEN-003, a Herpes Simplex Virus Immunotherapy, in a Phase 2b Study Open Forum Infectious Diseases. 4: S519-S519 |
| Schulte JM, Bellamy AR, Hook EW, et al. (2014) HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women). Southern Medical Journal. 107: 79-84 |
| Bernstein DI, Bellamy AR, Hook EW, et al. (2013) Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women Clinical Infectious Diseases. 56: 344-351 |
| Nour AM, Reichelt M, Ku CC, et al. (2011) Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complex. The Journal of Biological Chemistry. 286: 17921-33 |
| Govero J, Hall S, Heineman TC. (2007) Intracellular localization of varicella-zoster virus ORF39 protein and its functional relationship to glycoprotein K. Virology. 358: 291-302 |
| Hall SL, Govero JL, Heineman TC. (2007) Intracellular transport and stability of varicella-zoster virus glycoprotein K. Virology. 358: 283-90 |
| Klein NP, Holmes TH, Sharp MA, et al. (2006) Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine. 24: 5913-8 |
| Heineman TC, Schleiss M, Bernstein DI, et al. (2006) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. The Journal of Infectious Diseases. 193: 1350-60 |
| Schleiss MR, Heineman TC. (2005) Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Review of Vaccines. 4: 381-406 |